<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9995">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05685680</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-22-12-17</org_study_id>
    <nct_id>NCT05685680</nct_id>
  </id_info>
  <brief_title>Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal Carcimoma</brief_title>
  <official_title>Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer is the second leading cause of death in the West, and rectal cancer&#xD;
      accounts for about 25% of colon cancers&#xD;
&#xD;
      Low anterior resection has been the mainstay of rectal cancer surgery in low rectal cancer&#xD;
      since the 1970s. Although the best efforts of experienced surgeons, The local recurrence rate&#xD;
      is 3 to 33% in conventional surgery, while total mesorectal excision (TME) results indicate a&#xD;
      recurrence rate of less than 10%&#xD;
&#xD;
      The evolution of the concept of TME which was first revealed by Heald.in 1982 made a major&#xD;
      shift in the treatment strategies (Rodriguez-Luna et al,2015). The concept of TME was the&#xD;
      most important event in surgery for rectal cancer in the last two decades, because even&#xD;
      without a curative approach, the local recurrence decreased to 6 to 12%, and 5-year survival&#xD;
      improved by 53-87% TME described clear definitions of distal resection margin (DRM),&#xD;
      circumferential resection margin (CRM), and least number of harvested lymph nodes, so&#xD;
      oncological outcomes improved, locoregional recurrence and survival rates also influenced .&#xD;
&#xD;
      Laparoscopic total mesorectal excision (LTME) may be associated with less blood loss, earlier&#xD;
      recovery, and lower morbidity. Identification of the small nerves and vessels became easiear&#xD;
      because of laparoscopic magnified view of pelvis and thus prevents these injuries (Sajid et&#xD;
      al, 2019). Also, minimal surgical trauma will reduce the immunologic response and preserves&#xD;
      postoperative immunologic defenses. This may lead to low rate of infections as well as low&#xD;
      local recurrences and distant metastases in addition to, tissue handling with less&#xD;
      manipulation, 'may reduces the spread of cancer cells&#xD;
&#xD;
      TME in obese males with low and anterior rectal tumors is technically challenging especially&#xD;
      post neoadjuvant chemoradiotherapy due to distortion of the anatomical planes (Ng et al,&#xD;
      2014). In these patients, it is difficult to obtain a proper view of the dissection plane, in&#xD;
      open technique which threatens the integrity of TME and carries the risk of positive margins,&#xD;
      which is related to higher rates of local recurrence&#xD;
&#xD;
      LTME is a widely used approach for rectal cancers; although conversion rate varies from 1.2&#xD;
      to 17%, and it is higher if BMI is equal to or more than 30&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2022</start_date>
  <completion_date type="Anticipated">December 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison betewen laparoscopic and open teqnique in resection of rectal carcinoma and the involvement of the resection margin (R1), which is CRM involvement or DRM involvement.after resection.</measure>
    <time_frame>1year</time_frame>
    <description>R(resection margin of cancer of rectum) CRM circumferencial margin Or. DRM distal resection margin of cancer</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Rectal Carcinoma</condition>
  <arm_group>
    <arm_group_label>Group A laparoscopic group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group A laparoscopic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B open surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total mesorectal excision in rectal carcinoma</intervention_name>
    <description>total mesorectal excision laparoscopic versus open technique in management of rectal carcinoma</description>
    <arm_group_label>Group A laparoscopic group</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with pathologically confirmed rectal carcinoma involving middle or lower&#xD;
             third rectum and operable by MRI and CT scan criteria.&#xD;
&#xD;
          -  Both sexes will be included.&#xD;
&#xD;
          -  Age: ranging from 20 to 70 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with stage IV.&#xD;
&#xD;
          -  Recurrent rectal cancers.&#xD;
&#xD;
          -  Combined malignancy.&#xD;
&#xD;
          -  Patients admitted due to emergency situations (acute large bowel obstruction,&#xD;
             abdominal abscess, or rectal perforation and hemorrhage).&#xD;
&#xD;
          -  Patients with contraindication for laparoscopic surgery.&#xD;
&#xD;
          -  Unfit patients (ASA score &gt; II).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>osama s saleh, assistant lecture</last_name>
    <phone>01119966457</phone>
    <email>usama.mohamed@med.sohag.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>omar A abd el-raheem, professor</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sohag University Hospital</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdy M Amin, professor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Cecil TD, Sexton R, Moran BJ, Heald RJ. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum. 2004 Jul;47(7):1145-9; discussion 1149-50. doi: 10.1007/s10350-004-0086-6. Epub 2004 Jun 3.</citation>
    <PMID>15164243</PMID>
  </reference>
  <reference>
    <citation>Braga M, Frasson M, Vignali A, Zuliani W, Capretti G, Di Carlo V. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum. 2007 Apr;50(4):464-71. doi: 10.1007/s10350-006-0798-5.</citation>
    <PMID>17195085</PMID>
  </reference>
  <reference>
    <citation>Hill GL, Rafique M. Extrafascial excision of the rectum for rectal cancer. Br J Surg. 1998 Jun;85(6):809-12. doi: 10.1046/j.1365-2168.1998.00735.x.</citation>
    <PMID>9667714</PMID>
  </reference>
  <verification_date>December 2022</verification_date>
  <study_first_submitted>December 21, 2022</study_first_submitted>
  <study_first_submitted_qc>January 12, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2023</study_first_posted>
  <last_update_submitted>January 12, 2023</last_update_submitted>
  <last_update_submitted_qc>January 12, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Osama Saleh Ahmed</investigator_full_name>
    <investigator_title>Assistant lecture ofgeneral surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

